GI
ABEO icon

GAMMA Investing’s Abeona Therapeutics ABEO Stock Holding History

GAMMA Investing’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Buy
1,751
+842
+93% +$4.62K ﹤0.01% 3165
2026
Q1 		$4.07K Buy
909
+819
+910% +$4.09K ﹤0.01% 3439
2025
Q4 		$474 Buy
90
+42
+88% +$211 ﹤0.01% 3921
2025
Q3 		$253 Buy
+48
New +$304 ﹤0.01% 3788

Other funds holding ABEO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

GAMMA Investing's ABEO Position: Q2 2026 in Review

GAMMA Investing increased its Abeona Therapeutics (ABEO) stake by 93% in Q2 2026, buying an estimated $4.62K and bringing the position to 1,751 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3165.

GAMMA Investing first reported a position in ABEO in Q3 2025 and has held it in 4 quarters since. 6 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • GAMMA Investing held 1,751 shares of Abeona Therapeutics worth $10.8K as of Q2 2026.
  • GAMMA Investing bought 842 Abeona Therapeutics shares in Q2 2026, an estimated $4.62K.
  • Abeona Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3165 holding.
  • GAMMA Investing first reported a position in Abeona Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 6 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.